Hikma Pharmaceuticals to Buy Generic Drug Maker Roxane by CHAD BRAY

By CHAD BRAY

Hikma Pharmaceuticals agreed to pay about $2.65 billion in cash and shares for Boehringer Ingelheim’s generic drugs business in the United States.

Published: July 29, 2015 at 12:00AM

from NYT Business Day http://ift.tt/1D8fglc

from WordPress http://ift.tt/1SKKLDu
via Hadi Aboukhater